Skip to main content

abrdn Life Sciences Investors

HQL
Exchange
NYSE
SEC CIK
0000884121

In the last 90 days, abrdn Life Sciences Investors insiders filed 1 open-market purchase and 0 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $156.5M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding abrdn Life Sciences Investors changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of HQL: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders65650
Shares3.33M3.67M+339.1K (+10.2%)
Value$55.2M$52.3M−$2.88M (−5.2%)

New holders (9)

Institutions that held abrdn Life Sciences Investors at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to HQL in Q2 2022
InstitutionSharesValue% of portfolio
Advisors Asset Management, Inc.262,295$3.73M0.07%
Landscape Capital Management, L.L.C.18,163$258.0K0.03%
Cornerstone Advisors, LLC13,500$192.0K0.01%
Blue Bell Private Wealth Management, LLC2,455$35.0K0.01%
CoreCap Advisors, LLC559$8.00K0.00%
Northwestern Mutual Wealth Management Co445$6.00K0.00%
WFA of San Diego, LLC300$4.00K0.00%
Sargent Bickham Lagudis LLC164$2.00K0.00%
Atlas Capital Advisors LLC138$1.96K0.00%

Sold out (9)

Institutions that held abrdn Life Sciences Investors at the end of Q1 2022 and filed for Q2 2022 without it.